Integrated DNA Technologies Inc

Activities: Manufacturing Research & Development

Trending Articles

  1. Roche acquires clinical-stage biopharmaceutical company Poseida Therapeutics Through the merger, Roche will acquire Poseida's allogeneic CAR-T cell therapy portfolio, including pre-clinical and clinical-stage iterations for a range of conditions
  2. Aurobindo Pharma signs $25m respiratory drug development and commercialisation deal with global pharma company The companies will co-develop and commercialise respiratory therapeutics, diversifying Aurobindo's current portfolio
  3. IMed Consultancy helps Toby Orthopaedics navigate UK regulations Regulatory consultancy ensures compliance and confidence for Miami-based company
  4. Vetter strengthens senior management team for growth Three new managing directors to support global sustainable development
  5. Merck's Welireg approved for cancers associated with von Hippel-Lindau disease in China The once-daily drug is the first HIF-2α to be approved in China, exhibiting a 49% objective response rate (ORR)

Upcoming event

CPhI Middle East

10–12 December 2024 | Conference | Riyadh, Saudi Arabia See all

Related Content

Manufacturing

IDT launches rhAmpSeq CRISPR analysis system

Validation of specificity for CRISPR genome editing is important for researchers working toward Investigational New Drug (IND) filings which requires on- and off-target data analysis
Research & Development

IDT host a webinar on increasing target specificity with CRISPR

On 16 August Integrated DNA Technologies will host a webinar titled "Increase on-target specificity of CRISPR genome editing using a novel, high-fidelity Cas9 nuclease”
Research & Development

IDT partners with Illumina for NGS library preparation

Leaders in NGS tools collaborate to deliver robust multiplexing capabilities and streamline target enrichment methods
Distribution

IDT appoints LubioScience as distributors in Switzerland

Researchers in Switzerland no longer need to import IDT products – local expertise facilitates ordering
Research & Development

Integrated DNA Technologies acquires oligonucleotide synthesis company ValueGene

Adds new customers with promise to provide seamless support for genomics research
Distribution

Integrated DNA Technologies expands global sales network

Company now selling directly to customers in South Korea
Finance

Integrated DNA Technologies buys oligonucleotide synthesis business of AITbiotech

Increases firm's capacity to deliver locally manufactured products in Singapore
Subscribe now